SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO, CA--(Marketwired - Jul 28, 2014) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Quidel’s ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing for COVID-19 with ...

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic ...

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from Douglas Bryant, Quidel’s ...

Pac-12 first college athletics conference to offer a conference-wide daily rapid-results testing regimen to limit spread of COVID-19. SAN FRANCISCO - The Pac-12 Conference announced today that it has ...

Quidel Corporation has announced an exclusive, worldwide license to the MChip microarray based influenza detection technology developed by scientists at the University of Colorado (CU) in ...